Groupe d'Etude en Oncologie du Quebec

Titre	CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)
Protocole ID	CARMA-BROS
ClinicalTrials.gov ID	NCT04151342
Type(s) de cancer	Autre
Phase	Autres
Type étude	Autre
Institution	CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
Ville	Montréal
Investigateur(trice) principal(e)	Dr Normand Blais
Coordonnateur(trice)	Wiam Belkaid 514-890-8000
Statut	Actif en recrutement
Date d'activation	17-01-2024
Critètes d'éligibilité	Patients ≥ 18 years at cancer diagnosis Diagnosed with malignant tumour(s) with molecular testing completed that identified rare molecular alterations Accessible/available molecular testing reports/documentation to confirm type(s) of molecular alteration(s) (resulting from the conduct of polymerase chain reaction [PCR] based next generation sequencing [NGS], immunohistochemistry [IHC], fluorescence in situ hybridization [FISH]) Canadian resident received follow-up for cancer care in Canada or is currently receiving/planning follow-up for cancer care to occur in Canada at time of enrollment
Critètes d'exclusion	Previous refusal of the deceased patient, when living, to enroll in this study or patient approached for this study is unable to provide informed consent

Groupe d'étude en oncologie du Québec